Chronic Hepatitis B Virus (HBV) Infection research hub

A Platform Study Evaluating the Efficacy and Safety of Investigational Therapies in Participants with Chronic Hepatitis B Infection (PREVAIL)

This study, called PREVAIL, is testing new medicines for people with long-term Hepatitis B. It aims to see how well these new treatments can reduce the virus in the body and remove a specific marker of the infection.